We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Schroder Investment Management Group
251
Schroder Investment Management Group
United Kingdom
$729K +$671K +9,110 New
KeyBank National Association
252
KeyBank National Association
Ohio
$724K +$667K +9,059 New
ARMC
253
American Research & Management Company
Massachusetts
$721K +$663K +9,000 New
RFS
254
Rockefeller Financial Services
New York
$714K +$657K +8,922 New
DCM
255
DAFNA Capital Management
California
$689K +$633K +8,600 New
HCM
256
Harvey Capital Management
Florida
$688K +$633K +8,600 New
AIP
257
Ameritas Investment Partners
Nebraska
$681K +$626K +8,500 New
Caisse de Depot et Placement du Quebec (CDPQ)
258
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$655K +$604K +8,200 New
QI
259
QS Investors
New York
$654K +$597K +8,100 New
PCM
260
Prelude Capital Management
New York
$652K +$600K +8,146 New
Walleye Trading
261
Walleye Trading
New York
$644K +$592K +8,044 New
EWM
262
Endurance Wealth Management
Rhode Island
$640K +$589K +8,000 New
Commonwealth Equity Services
263
Commonwealth Equity Services
Massachusetts
$581K +$534K +7,253 New
AAM
264
Advisors Asset Management
Colorado
$559K +$516K +7,000 New
Korea Investment Corp
265
Korea Investment Corp
South Korea
$559K +$516K +7,000 New
VRS
266
Virginia Retirement Systems
Virginia
$549K +$505K +6,859 New
V
267
Veritable
Delaware
$548K +$504K +6,845 New
Group One Trading
268
Group One Trading
Illinois
$546K +$503K +6,836 New
Mirae Asset Global Investments
269
Mirae Asset Global Investments
South Korea
$538K +$495K +6,715 New
SAM
270
Silvercrest Asset Management
New York
$530K +$488K +6,624 New
ICRM
271
Insight Capital Research & Management
California
$529K +$486K +6,605 New
MA
272
MUFG Americas
New York
$529K +$488K +6,628 New
Daiwa Securities Group
273
Daiwa Securities Group
Japan
$520K +$479K +6,500 New
WFM
274
Wilmington Funds Management
Delaware
$478K +$441K +5,983 New
DILH
275
Dai-ichi Life Holdings
Japan
$456K +$420K +5,707 New
9 10
11
12 13

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.